Rifampicin test in the diagnosis of Gilbert's syndrome

International Journal of Clinical Practice

Volumn 55, Issue 2, 2001, Pages 81-83

  Erdil, A ^a   Kadayifci, A ^b   Es, Y A T ^c   Bagci, S ^a   Uygun, A ^b   Dag Alp, K ^c  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c Ural Apt No 9 ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; RIFAMPICIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CALORIC INTAKE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIET; FEMALE; GILBERT DISEASE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIDE EFFECT;

ENZYME INHIBITORS; FASTING; FEMALE; GILBERT DISEASE; HUMANS; HYPERBILIRUBINEMIA; MALE; RIFAMPIN; SENSITIVITY AND SPECIFICITY;

EID: 0035083630     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. .Watson KJR, Gollan JL. Gilbert's syndrome. Baillicres din Gastmenterol 1989; 3: 337-355.
2. Powell, LW. Hemingway, E. Billing, BH. Sherlock. S. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome): a study of 42 families. N Engl J Mi'd 1967: 277: 1108-1112.
3. Owens D. Sherlock S. Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. BMJ 1973; 3: 559-563.
4. Rollinghoff W. Paumgartner G. Preisig R. Nicotinic acid test in the diagnosis of Gilbert's syndrome: correlation with bilirubin clearance. Gut 1981; 22: 663-668.
5. Pérez Blanco FJ. Martin Rui'z JL, Caballero Plasencia A el til. The nicotinic acid and rifampicin tests in Gilbert's syndrome. Rev F.sp F.nferm Apar Dig 1985:68: 127-130.
6. Noguerado Asensio A, Mear'in Manrique F. Fscudero Sereno V el til. Gilbert's syndrome: comparative study of fasting and rifampicin as diagnostic tests. Rev Esp Enferm Apar Dig 1986; 69: 133-135.
7. Velilla Alcubilla JP, Garcfa Mauriz E, MartfneJ. Bruna MS et al. The rifampicin test in the diagnosis of Gilbert's syndrome. Alen Primarici 1993: 11: 84-86.
8. Felsher BF. Effect of changes in dietary components on the serum bilirubin in Gilbert's syndrome. Am J Clin Niitr 1976; 29: 705-709.
9. Felsher BF, Rickard D, Redeker AG. The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome. N EnxU Med 1970:283: 170-172.
10. Gentile S, Orzes N, Persico M el al. Comparison of nicotinic acid- and caloric restriction-induced hyperbilirubinaemia in the diagnosis of Gilbert's syndrome. J Hepalol 19X5: 1: 537-543.
11. Mendoza Hernandez JL. Garcia Paredes J. Larrubia Marfil JR el al. Diagnosis of Gilbert's syndrome: current status of the fasting test. Ann Med Interna 1997; 14: 57-61.
12. Bloomer JR, Barre PV. Rodkey FL, Berlin NI. Studies on the mechanism of fasting hyperbilirubinemia. Gastroenterologe 1971: 61: 479-482.
13. Olsson R. Stigendal L. Clinical experience with isolated hyperbilirubinemia. Sctind J Gastmenterol 1989: 24: 617-622.
14. Olsson R. Lindstedt G. Evaluation of tests for Gilbert's syndrome. Ada Med Scant! 1980: 207: 425-428.
15. Kajser L. Eklund B. Olsson G, Calson L. Dissociation between the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man. Med Rial 1979: 57: 114 117.
16. Capclle P. Dhumeaux D. Mora M et til. Effect of rifampicin on liver function in man. Gut 1972; 13: 366-371.
17. Galeazzi R. Lorenzini I. Orlandi F. Rifampicin-induced elevation of serum bile acids in man. Dig Dix Sei 1980; 25: 108-112.
18. Anwer MS. Kroker R. Hegner D. Inhibition of hepatic uptake of bile acids by rifamycins. Arch Plmrmaml 1978: 302: 19-24.